Monoallelic knockout of HDAC9 in the Raji Burkitt's lymphoma cell line (biallelic forms were non-viable; data not shown) led to reductions in HDAC9, consistent with a decrease in gene dosage (Fig. 6A). This evidence concerns the gene HDAC9 and Burkitt lymphoma.